(Q43745083)

26 November 2017

title

Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice (English)

1 reference

26 November 2017

Yamada J

1

1 reference

26 November 2017

Sugimoto Y

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

427

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

221-225

1 reference

5-HT2 receptor subtypes: a family re-united?

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Role of the serotonergic system in the forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Evidence that imipramine activates 5-HT1C receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901240-7

10.1016/S0014-2999(01)01240-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference